文献速递瓣膜外科

抗生素疗程对活动性感染性心内膜炎术后复发与生存的影响

Impact of the duration of antibiotic therapy on relapse and survival following surgery for active infective endocarditis.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该回顾性观察研究纳入2004年1月至2015年12月因急性感染性心内膜炎接受手术的182例患者,术后抗生素中位疗程23.5天(IQR 12-40天),研究期间显著缩短(P<0.001)。术后抗生素疗程未影响复发、早期再手术或1年死亡率,支持部分患者可安全缩短术后抗生素疗程。

要点

  • 术后抗生素中位疗程23.5天,研究期间显著缩短(P<0.001)。
  • 复发2例(1.1%),1年内死亡18例(9.9%),早期再手术9例(5%)。
  • 术后抗生素疗程与复发、早期再手术及1年死亡率均无关。

核心结论

  • 在活动性感染性心内膜炎需手术的患者中,术后抗生素疗程不影响复发或生存,支持选择性缩短疗程。

研究设计与样本

  • 回顾性观察研究,纳入2004年1月至2015年12月因急性感染性心内膜炎接受手术的182例患者。

主要发现

  • 术后抗生素中位疗程23.5天(IQR 12-40天),研究期间显著缩短(P<0.001)。
  • 复发2例(1.1%),术后1年内死亡18例(9.9%),早期再手术9例(5%)。
  • 术后抗生素疗程未影响主要结局(复发)或次要结局(早期再手术、1年死亡率)。

临床怎么用

  • 对选定活动性感染性心内膜炎术后患者,可考虑缩短术后抗生素疗程而不增加复发风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Surgery is often required for acute infective endocarditis (IE) to repair or replace damaged heart valves. Traditionally, long courses of antibiotic treatment have been prescribed after surgery for active IE for fear of infecting newly implanted/repaired valves, but the need for this, in the present era of enhanced antimicrobial stewardship, has been questioned. In our institution, the choice and duration of antimicrobial therapy is tailored to individual patients by a multidisciplinary team with an interest in IE. The influence of the duration of postoperative antibiotic therapy on outcomes was studied in patients requiring surgery prior to the completion of a planned course of antibiotic therapy. METHODS: This was a retrospective observational study on patients with acute IE requiring surgery between January 2004 and December 2015. The primary outcome was relapse. Secondary outcomes were early reoperation and 1-year mortality. RESULTS: In total, 182 IE episodes were included in the final analysis. The median duration of postoperative antibiotic therapy was 23.5 days (interquartile range 12-40 days) and decreased significantly during the period of study (P < 0.001). There were 2 relapses (1.1%) and 18 (9.9%) postoperative deaths within 1 year. Nine (5%) patients underwent early reoperation. The duration of postoperative antibiotic therapy did not affect either the primary or the secondary outcomes. CONCLUSIONS: This work supports previous findings that selected patients who require surgery during active IE can be safely given shorter courses of postoperative antibiotics without an impact on relapse of infection or survival.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Rao VP, Wu J, Gillott R, et al. Impact of the duration of antibiotic therapy on relapse and survival following surgery for active infective endocarditis. Eur J Cardiothorac Surg. 2019. PMID: 30307552. doi:10.1093/ejcts/ezy325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。